Working… Menu
Trial record 10 of 538 for:    IFNA2 AND RBV AND Hepatitis

A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00854802
Recruitment Status : Completed
First Posted : March 3, 2009
Last Update Posted : February 17, 2016
Information provided by (Responsible Party):
Debiopharm International SA

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2010
Actual Study Completion Date : September 2010